Sarah C. Glover

4.0k total citations
114 papers, 1.9k citations indexed

About

Sarah C. Glover is a scholar working on Surgery, Genetics and Immunology. According to data from OpenAlex, Sarah C. Glover has authored 114 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 38 papers in Genetics and 35 papers in Immunology. Recurrent topics in Sarah C. Glover's work include Inflammatory Bowel Disease (33 papers), Eosinophilic Esophagitis (18 papers) and Microscopic Colitis (17 papers). Sarah C. Glover is often cited by papers focused on Inflammatory Bowel Disease (33 papers), Eosinophilic Esophagitis (18 papers) and Microscopic Colitis (17 papers). Sarah C. Glover collaborates with scholars based in United States, United Kingdom and Italy. Sarah C. Glover's co-authors include Jian Li, Corey A. Siegel, Richard V. Benya, Scott D. Lee, Uma Mahadevan, Marla C. Dubinsky, Thomas Ullman, Jocelyn Miller, Douglas C. Wolf and Antoine Cortot and has published in prestigious journals such as The Lancet, The Journal of Immunology and Gastroenterology.

In The Last Decade

Sarah C. Glover

106 papers receiving 1.8k citations

Peers

Sarah C. Glover
John L. Wagner United States
Marc Busson France
Man‐Chiu Poon Canada
Graham Davies United Kingdom
Fatma Dedeoğlu United States
Robert P. Nelson United States
Steen Sørensen Denmark
Raphael Hirsch United States
Edward J Carr United Kingdom
A. B. Peck United States
John L. Wagner United States
Sarah C. Glover
Citations per year, relative to Sarah C. Glover Sarah C. Glover (= 1×) peers John L. Wagner

Countries citing papers authored by Sarah C. Glover

Since Specialization
Citations

This map shows the geographic impact of Sarah C. Glover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah C. Glover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah C. Glover more than expected).

Fields of papers citing papers by Sarah C. Glover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah C. Glover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah C. Glover. The network helps show where Sarah C. Glover may publish in the future.

Co-authorship network of co-authors of Sarah C. Glover

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah C. Glover. A scholar is included among the top collaborators of Sarah C. Glover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah C. Glover. Sarah C. Glover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Therrien, Amélie, Jocelyn A. Silvester, Daniel A. Leffler, et al.. (2025). Hereditary Alpha-Tryptasemia Is Associated With Ongoing Symptoms in Individuals With Celiac Disease Despite Following a Gluten-free Diet. The American Journal of Gastroenterology. 121(2). 517–525.
2.
3.
Abadir, Alexander, Hyder Said, Anna H. Owings, et al.. (2023). 680 A LARGE MULTICENTER STUDY ASSESSING FACTORS CAUSING DELAYS IN INITIATING BIOLOGIC OR NOVEL SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.. Gastroenterology. 164(6). S–134. 1 indexed citations
4.
Glover, Sarah C., et al.. (2022). Sodium-Glucose Cotransporter 2 Inhibitor Use Among Individuals Age. ClinicoEconomics and Outcomes Research. Volume 14. 465–477. 4 indexed citations
5.
Owings, Anna H., et al.. (2022). Urinary manifestations in African American and Caucasian inflammatory bowel disease patients: a retrospective cohort study. BMC Urology. 22(1). 1–1. 6 indexed citations
6.
Fransen, Signe, Chuanbo Xu, Jeffrey P. Gregg, et al.. (2021). S346 Enrollment Rate of African Americans in a Colon Cancer Screening Trial at a Historically Black College and University Is Similar to Other Patient Populations. The American Journal of Gastroenterology. 116(1). S149–S150. 1 indexed citations
7.
Pallav, Kumar, et al.. (2021). Escherichia coli O157: H7 sepsis following fecal microbiota transplant in an IgA-deficient inflammatory bowel disease patient. Gastroenterology report. 10. goab041–goab041. 2 indexed citations
8.
Newsome, Rachel C., Josée Gauthier, George Abraham, et al.. (2021). The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut Microbes. 13(1). 1–15. 52 indexed citations
9.
Capitano, Maegan L., Aruna S. Jaiswal, Hal E. Broxmeyer, et al.. (2021). A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease. PLoS ONE. 16(7). e0252805–e0252805. 4 indexed citations
10.
Walker, Jean, et al.. (2021). The Impact of Transition Readiness and Stress on Patient-Centered Outcomes in Young Adults With Inflammatory Bowel Disease. Gastroenterology Nursing. 44(4). 259–267. 5 indexed citations
11.
Mateja, Allyson, Jack Chovanec, Ji-Won Kim, et al.. (2021). Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis. Journal of Allergy and Clinical Immunology. 149(3). 1010–1017.e10. 47 indexed citations
12.
Osterman, Mark T., Kelli L. VanDussen, Ilyssa O. Gordon, et al.. (2020). Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn’s Disease. Inflammatory Bowel Diseases. 27(5). 677–685. 9 indexed citations
13.
Danese, Silvio, William J. Sandborn, Jean‐Frédéric Colombel, et al.. (2019). Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn’s Disease. Gastroenterology. 157(4). 1007–1018.e7. 142 indexed citations
14.
Stewart, Daniel, Jian Li, Xinyue Liu, et al.. (2018). Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease. PLoS ONE. 13(7). e0200377–e0200377. 54 indexed citations
15.
Li, Jian & Sarah C. Glover. (2018). Innate Lymphoid Cells in Inflammatory Bowel Disease. Archivum Immunologiae et Therapiae Experimentalis. 66(6). 415–421. 15 indexed citations
16.
Zhang, Dongwei, Sarah C. Glover, Weidong Liu, Xiuli Liu, & Jinping Lai. (2018). Small Bowel Pyogenic Granuloma With Cytomegalovirus Infection in a Patient With Crohn's Disease (Report of a Case and Review of the Literature). In Vivo. 33(1). 251–254. 4 indexed citations
17.
Collinsworth, Amy, et al.. (2016). Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn’s disease: a case report. Journal of Medical Case Reports. 10(1). 264–264. 1 indexed citations
18.
Coman, Roxana M., Sarah C. Glover, & Altin Gjymishka. (2014). Febrile pleuropericarditis, a potentially life-threatening adverse event of balsalazide – case report and literature review of the side effects of 5-aminosalicylates. Expert Review of Clinical Immunology. 10(5). 667–675. 9 indexed citations
19.
Serebryannyy, Leonid, Madelyne Z. Greene, Wen-Yang Hu, et al.. (2013). Tumor Stiffness Is Unrelated to Myosin Light Chain Phosphorylation in Cancer Cells. PLoS ONE. 8(11). e79776–e79776. 8 indexed citations
20.
Vishnubhotla, Ramana V., Marinka Bulic, Cécile M. Perrault, et al.. (2010). The extracellular matrix microtopography drives critical changes in cellular motility and Rho A activity in colon cancer cells. Cancer Cell International. 10(1). 24–24. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John L. Wagner Breakdown of academic impact, for papers by Marc Busson Breakdown of academic impact, for papers by Man‐Chiu Poon Breakdown of academic impact, for papers by Graham Davies Breakdown of academic impact, for papers by Fatma Dedeoğlu Breakdown of academic impact, for papers by Robert P. Nelson Breakdown of academic impact, for papers by Steen Sørensen Breakdown of academic impact, for papers by Raphael Hirsch Breakdown of academic impact, for papers by Edward J Carr Breakdown of academic impact, for papers by A. B. Peck
Rankless by CCL
2026